LUNG CANCER 2003-2006. Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

Slides:

Advertisements

Similar presentations

Canadian Cancer Risk Management Model: A new health policy tool useful in policy decisions related to lung cancer WK Evans, M Wolfson, WM Flanagan, J Oderkirk,

Advertisements

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

CRC-1 The Need for 3rd-Line Therapy in Non-Small Cell Lung Cancer Frances A. Shepherd, MD Scott Taylor Chair in Lung Cancer Research Princess Margaret.

Lung Cancer Morbidity in Baltimore City & Chicago By Calandra Dyson Lyliane Mbah MoniQue Veney Promise Okafor.

TYPES, CAUSES, SYMPTOMS, TREATMENTS, STATISTICS, & PICTURES HEATHER XXXXXXX, 1 ST PERIOD Lung Cancer 1

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

The treatment of metastatic squamous cell carcinoma (SCCA) of the anal canal: A single institution experience P. Pathak, B. King, A. Ohinata, P. Das, C.H.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Acknowledgements This report differs from the submitted abstract due to further subdivision of patients into analytic and non- analytic, and focus on the.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

Lung Cancer Angel.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

Su K. Metcalfe, MD, MPH, Michael T

NON-SMALL CELL LUNG CANCER

Lung squamous cell carcinoma

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Johns Hopkins Hospital Malignant and Benign Brain/CNS

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Johns Hopkins Hospital Cancer Registry

تهیه کننده: استاد مربوطه: بهار 1392

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Lung Cancer (C33-C34): Number and Proportion of Cases Diagnosed at Each Stage, Adults 15-99, Former Anglia Cancer Network Percentage of Total.

Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E

Joshua E. Rosen, BASc, Michelle C

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain.

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer Walter Weder, MD, Stéphane Collaud, MD,

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials Krista.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer Eric D. Miller, MD,

Yang Zhang, MD, Haiquan Chen, MD, PhD

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy Naomi E. Verstegen,

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Daniel Morgensztern, MD, Shean Huey Ng,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer Martin J. Edelman, MD, Mohan Suntharalingam,

Treatment of Stage III Non-small Cell Lung Cancer

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Presentation transcript:

LUNG CANCER

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases by Class of Case, n=1364 MaleFemaleTotal Class Class Class Class Total Analytic: Class 0, 1, 2 Non-Analytic: Class 3

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases Age at Diagnosis n= /10 4/

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases by Race n= /8 18/16

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases Maryland by County n=1018

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases by State n=1364

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , Analytic Class 1 & 2 by AJCC Stage n= There were 4 class 0

Johns Hopkins Hospital Lung Cancer, Non-Small Cell , Analytic Class 1&2 by Treatment, n=1182

Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC I Percentage % Maryland JHHNational Surgery Only Radiation Radiation & Chemotherapy Chemotherapy only Surgery, Radiation & Chemotherapy Other No Treatment TOTAL Source NCDB, Commission on Cancer, ACoS/ACS

Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC II Percentage % Maryland JHHNational Surgery Only Radiation Radiation & Chemotherapy Chemotherapy only Surgery, Radiation & Chemotherapy Other No Treatment TOTAL Source NCDB, Commission on Cancer, ACoS/ACS

Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC III Percentage % Maryland JHHNational Surgery Only Radiation Radiation & Chemotherapy Chemotherapy only Surgery, Radiation & Chemotherapy Other No Treatment TOTAL Source NCDB, Commission on Cancer, ACoS/ACS

Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC IV Percentage % Maryland JHHNational Surgery Only Radiation Radiation & Chemotherapy Chemotherapy only Surgery, Radiation & Chemotherapy Other No Treatment TOTAL Source NCDB, Commission on Cancer, ACoS/ACS

Johns Hopkins Hospital Lung Cancer, Non-Small Cell, , Analytic Class 1&2. Relative Survival n=474

Relative 5 Year Survival Lung Cancer, Non-Small Cell, , State of Maryland, n = 3382 Source NCDB, Commission on Cancer, ACoS/ACS

Relative 5 Year Survival Lung Cancer, Non-Small Cell, , Teaching Hospitals, n = Source NCDB, Commission on Cancer, ACoS/ACS

Relative 5 Year Survival NSCLC , JHH vs MD vs National AJCC Stage I Source NCDB, Commission on Cancer, ACoS/ACS

Relative 5 Year Survival NSCLC , JHH vs MD vs National AJCC Stage II Source NCDB, Commission on Cancer, ACoS/ACS

Relative 5 Year Survival NSCLC , JHH vs MD vs National AJCC Stage III Source NCDB, Commission on Cancer, ACoS/ACS

Relative 5 Year Survival NSCLC , JHH vs MD vs National AJCC Stage IV Source NCDB, Commission on Cancer, ACoS/ACS